Features of beta cell differentiation during the development of type 2 diabetes mellitus

Type 2 diabetes mellitus is characterized by a mild inflammatory reaction in the pancreas, which affects the structure and function of the pancreatic islets: the number of β-cells decreases and the number of α-cells increases. The work examined the features of β-cell differentiation in the development of experimental type 2 diabetes mellitus and while reducing the inflammatory process. Biochemical, histological methods, enzyme-linked immunosorbent assay, immunohistochemical methods were used using primary antibodies to insulin, glucagon, proliferation marker Ki-67 and secondary antibodies labeled with fluorescent dyes. Streptozotocin and nicotinamide were used to model type 2 diabetes mellitus, and the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4-dione was used to reduce the inflammatory response. Previous studies have shown that it changes the macrophage phenotype from proinflammatory M1 to anti-inflammatory M2. In type 2 diabetes mellitus, against the background of a decrease in the number of macrophages with the CD163 marker and the concentration of the cytokine TGF-β1, which have an anti-inflammatory effect, in the pancreatic islets, a decrease in the number of β-cells and their functional activity was observed, while the content of α-cells synthesizing glucagon increased. After administration of the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4-dione, the opposite picture was observed in the pancreatic islets: against the background of an increase in the number of CD163⁺ macrophages and the content of TGF-β1, the number of β cells increased and the number of α cells decreased-cells. The increase in the number of insulin-synthesizing cells was not accompanied by their mitotic activity. It is likely that a decrease in the number of CD163⁺ macrophages and the level of the antiinflammatory cytokine TGF-β1 in the islets are factors contributing to changes in the cell microenvironment and, as a consequence, the differentiation of β-cells into α-cells. On the contrary, an increase in the number of CD163⁺ macrophages and TGF-β1 against the background of administration of the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4-dione presumably promotes reverse differentiation of α-cells into β-cells and restoration of insulin synthesis pancreas. Targeted effects on the microenvironment of cells in the pancreatic islet in type 2 diabetes mellitus may be a new approach to treating the disease.

1. Bulavintseva T.S., Yushkov B.G., Danilova I.G., Abidov M.T. Influence of macrophages on the insulin-synthesizing system under normal conditions and in alloxan diabetes. Meditsinskaya immunologiya = Medical Immunology (Russia), 2023, Vol. 25, no. 2, pp. 287-300. (In Russ.) doi: 10.15789/10.15789/1563-0625-IOM-2534.

2. Gette I.F., Emelianov V.V., Belousova A.V., Danilova I.G., Sidorova L.P., Tseitler T.A. The influence of a number of substituted 1,3,4-6h-thiadiazines on the content of cytokines in blood plasma of rats with experimental diabetes mellitus type2. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2019, Vol. 13, no. 3 (22), pp. 103-1107. (In Russ.) doi: 10.31857/S102872210007234-2.

3. Anquetil F., Sabouri S. Alpha cells, the main source of IL-1β in human pancreas. J. Autoimmun., 2017, Vol. 81, pp. 68-73.

4. Cassado ADA. F4/80 as a Major Macrophage Marker: The Case of the Peritoneum and Spleen. Results Probl. Cell Differ., 2017, Vol. 62, pp. 161-179.

5. Danilova I.G. Partial recovery from alloxan-induced diabetes by sodium phthalhydrazide in rats. Biomed. Pharmacother., 2017, Vol. 95, pp. 103-110.

6. Donath M., Shoelson S. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol., 2011, Vol. 11, pp. 98-107.

7. Efrat S. Beta-Cell Dedifferentiation in Type 2 Diabetes: Concise Review. Stem Cells, 2019, Vol. 37, no. 10, pp. 1267-1272.

8. Ghasemi A., Khalifi S., Jedi S. Streptozotocin-nicotinamide-induced rat model of type 2 diabetes. Acta Physiol. Hung., 2014, Vol. 101, no. 4, pp. 408-420.

9. Ito M. Characterization of low dose streptozotocin-induced progressive diabetes in mice. Environ. Toxicol. Pharmacol., 2001, Vol. 9, no. 3, pp. 71-78.

10. Khin P.P., Lee J.J. A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes. Nutrients, 2021, Vol. 13, no. 5, 1593. doi: 10.3390/nu13051593.

11. Puri S., Folias A.E. Hebrok M. Plasticity and Dedifferentiation within the Pancreas: Development, Homeostasis, and Disease. Cell Stem Cell, 2015, Vol. 16, no. 1, pp. 18-31.

12. Schindelin J. Fiji: an open-source platform for biological-image analysis. Nat. Methods, 2012, Vol. 9, no. 7, pp. 676-682.

13. Sharma R. Experimental Models on Diabetes : A Comprehensive Review. Int. J. Adv. Pharm. Sci., 2013, Vol. 4, pp. 1-8.

14. Stirling D.R. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics, 2021, Vol. 22, pp. 1-11.